von Tobias Borgers | Apr. 3, 2021 | Continuous Manufacturing
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) — The „Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth...
von Tobias Borgers | Apr. 1, 2021 | Continuous Manufacturing
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) — Rentschler Biopharma SE, a leading global contract development and...
von Tobias Borgers | März 28, 2021 | Continuous Manufacturing
The drug sector has batch production in its DNA. Traditionally, medicines have been made in batches in multi-product facilities with the downtime between runs being used to clean manufacturing systems. The goals were speed and cost efficiency. Oversight of the...
von Tobias Borgers | März 25, 2021 | Continuous Manufacturing
Collaboration has widely been deemed a silver lining of the Covid-19 pandemic. The word ‘unprecedented’ has certainly been overused in the past year, but nowhere is it more apt than in describing the actions of pharma companies big and small working together to tackle...
von Tobias Borgers | März 24, 2021 | Tablettenproduktion
Dänemark ist beliebt, auch als Arbeitgeber: Nach dem Absturz von Novozymes hält Novo Nordisk die Stellung der Skandinavier in den Top 3 und verbessert sich vom dritten auf den zweiten Platz. (Bild: Novo Nordisk) 10. Nov. 2020 | 08:11 Uhr | von Armin Scheuermann Novo...
von Tobias Borgers | März 24, 2021 | Continuous Manufacturing
Pharmaceutical manufacturers face challenges ranging from emerging drug needs to tighter regulatory controls. Here, Emily Newton looks at how many company leaders are embracing trends that could forever change pharmaceutical production.Embracing technology to overcome...
